Panbela Therapeutics Inc expected to post a loss of $3.70 a share - Earnings Preview

Panbela Therapeutics

14/03/2023 20:50

* Panbela Therapeutics Inc  PBLA.OQ   PBLA.O  is expected
to show
no change in quarterly revenue when it reports  results on March
16. 
    * 
    * ​Refinitiv's mean analyst estimate for Panbela
Therapeutics Inc
is for a loss of $3.70 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $10​, above​ its last closing price
of $0.72. ​​​

This summary was machine generated March 14 at 20:50 GMT.  All
figures in US dollars  unless otherwise stated